Home/Filings/4/0001213900-22-030210
4//SEC Filing

Tesi Raymond Joseph 4

Accession 0001213900-22-030210

CIK 0001711754other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 6:10 AM ET

Size

4.6 KB

Accession

0001213900-22-030210

Insider Transaction Report

Form 4
Period: 2022-05-26
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2022-05-26$6.41/sh+6,300$40,3831,520,698 total
Footnotes (1)
  • [F1]Represents the average purchase price at a range of between $6.37 and $6.43 per share.

Documents

1 file

Issuer

Inmune Bio, Inc.

CIK 0001711754

Entity typeother

Related Parties

1
  • filerCIK 0001767280

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:10 AM ET
Size
4.6 KB